Gamma Investing LLC Innate Pharma Sa Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Innate Pharma Sa stock. As of the latest transaction made, Gamma Investing LLC holds 3,456 shares of IPHA stock, worth $7,153. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,456
Previous 2,233
54.77%
Holding current value
$7,153
Previous $3.98 Million
57.81%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IPHA
# of Institutions
11Shares Held
92.1KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY51.2KShares$106,0330.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il26.6KShares$55,0970.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7KShares$24,1380.0% of portfolio
-
Ubs Group Ag5.96KShares$12,3300.0% of portfolio
-
Rhumbline Advisers Boston, MA470Shares$9720.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $165M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...